Board of Directors

Marc Barbeau
Ovivo
Marc Barbeau, C.A. and master in taxation, is President /CEO at Ovivo . Prior to joining Ovivo, he held different positions at Raymond Chabot Grant Thornton accounting firm and at Groupe Laperrière & Verreault inc.
Michel A. Brunet
Dentons Canada
Michel A. Brunet, Chair and Chief Executive Officer of Dentons Canada LLP, has more than 30 years of experience in selling, acquiring and financing businesses.
Carl Deslongchamps
KPMG
Carl Deslongchamps, D.E.S.S. Fisc., is a Partner with the R&D and Strategic Relocation and Expansion Services (SRES) Groups in KPMG's Montreal office. He has a Bachelor of Commerce degree, with a Finance option, and a Diploma in Taxation. Before joining KPMG's team in September 2000, he held the position of Assistant Director, Tax Incentives Section in the Montreal Tax Services Office of the Canada Revenue Agency (CRA).
Dr. Nicolas Dupré
Centre hospitalier affilié universitaire de Québec
Dr. Dupré is a clinical and research neurologist who specialises in neuromuscular and neurogenetic diseases. His practice is at the Centre hospitalier affilié universitaire de Québec (Enfant-Jésus Hospital), and he is also an Associate Professor in the Faculty of Medicine at Laval University. Dr. Dupré endeavours to discover the genes that determine a predisposition to neurodegenerative diseases in the population of Quebec, such as hereditary ataxias. He works in close collaboration with the Brain Disease Research Center (Université de Montréal), where he is a member of Dr. Guy Rouleau’s laboratory.
Dr. Martin Godbout
Genome Canada
Dr. Martin Godbout holds a B.Sc. in biochemistry and a Ph.D. in physiology and molecular endocrinology from Laval University. From 1985 to 1990, he received a postdoctoral fellowship from the Medical Research Council (MRC) of Canada and was trained in Neuromolecular Biology at the Scripps Research Institute in California. Since April 1, 2000, Dr. Godbout has been the President and CEO of Genome Canada, a private, not-for-profit corporation, dedicated to investing and implementing a national strategy in genomics and proteomics research in Canada.
Jean Groleau
Groleau Gauthier Plante
Jean Groleau is a fiscal lawyer and partner at Groleau Gauthier Plante law firm. He is the co-founder and president of the Ataxia of Charlevoix-Saguenay Foundation.
Robert Guy
Wells Fargo
Robert Guy, a graduate from Concordia University, held different positions at Royal Bank and National Bank and at GE Capital Canada. Mr Guy is currently senior Vice President at Wells Fargo in Montreal.
Jacques Marchand
Jacques Marchand has a bachelor degree from l'École des Hautes Études Commerciales and a MBA from the Université du Québec in Montréal. Over the years, he held different positions at the National Bank of Canada and at Centria.
Dr. Jacques Michaud
Centre de recherche du CHU Sainte-Justine
Dr.Jacques Michaud completed his training in pediatrics and medical genetics at the University of Montreal and the University of Toronto. He then continued a genetic research training at the College de France in Paris, then at the Carnegie Institution of Washington / Johns Hopkins University in Baltimore. On his return in 1999, he chose to pursue a clinician scientist career. Clinical and research activities of Dr. Michaud is focused on the genetics of the neuro-development disorders.
Dr. Guy A. Rouleau
Centre de Recherche du CHU Ste-Justine
Born in Ottawa, Dr. Guy Rouleau graduated from the University of Ottawa with a medical degree in 1980 and spent the next five years pursuing training as a clinical specialist in neurology at McGill University in Montréal. Currently an Associate Professor at McGill University, he also directs the Molecular Neurogenetics Laboratory at the McGill University Centre for Research in Neurosciences. He is also research director at the CHU Ste Justine Research Centre.